Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Cocrystal Pharma Q2 EPS $(0.04) Up From $(0.07) YoY

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year.

byBill Haddad

August 16, 2021

1 minute read

Cocrystal Pharma (NASDAQ:COCP) reported quarterly losses of $(0.04) per share. This is a 42.86 percent increase over losses of $(0.07) per share from the same period last year.

Roche’s Polivy Combo Regime Under FDA Review For Type Of Blood Cancer

By Vandana Singh

Today, 2:16 AM

Roche Holdings AG (OTC:RHHBY) announced that the FDA accepted its supplemental marketing application for Polivy. Polivy is being developed by Roche…

RHHBF

Earnings Scheduled For August 30, 2021

By Lisa Levin

Today, 2:16 AM

Companies Reporting Before The Bell Catalent Inc (NYSE: CTLT) is expected to report quarterly earnings at $1.03 per share on revenue of $1.14 billion.

AKTS